Effects of stable transfection of human fetal osteoblast cells with estrogen receptor-alpha on regulation of gene expression by tibolone

A. Maran, K. Shogren, M. Zhang, Michael J Yaszemski, T. E. Hefferan, T. C. Spelsberg, H. J. Kloosterboer, R. T. Turner

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Tibolone is a synthetic steroid which undergoes tissue selective metabolism into several metabolites having estrogenic, progestogenic or androgenic activities. The effects of 3α-hydroxy tibolone (Org 4094), 3β-hydroxy tibolone (Org 30126) and their sulfated metabolites were investigated on human fetal osteoblasts (hFOB). Tibolone had no effect on selected osteoblast marker proteins in estrogen-receptor negative hFOB cells. In contrast, 3α-hydroxy and 3β-hydroxy tibolone resulted in dose-dependent increases in alkaline phosphatase activity in estrogen receptor (ER) α-positive hFOB cells. The maximum increase for both metabolites was comparable to the effects of an optimal dose of 17β-estradiol, and occurred at 10 μM. At 20 μM, both metabolites increased mRNA levels for alkaline phosphatase and type 1 collagen and protein levels for osteocalcin. Sulfated metabolites of tibolone also increased alkaline phosphatase activity. The estrogen receptor antagonist ICI 182, 780 inhibited stimulation of alkaline phosphatase activity by sulfated and non-sulfated tibolone metabolites, but was more potent on the former. Taken together, these results suggest that stable transfection of ERα into hFOB cells confers regulation by 3α-hydroxy and 3β-hydroxy tibolone metabolites of osteoblast metabolism.

Original languageEnglish (US)
Pages (from-to)523-529
Number of pages7
JournalBone
Volume39
Issue number3
DOIs
StatePublished - Sep 2006

Fingerprint

tibolone
Estrogen Receptor alpha
Gene Expression Regulation
Osteoblasts
Transfection
Alkaline Phosphatase
Estrogen Receptors
Osteocalcin
Collagen Type I

Keywords

  • Alkaline phosphatase
  • Anti-estrogen
  • Bone formation
  • Osteoporosis
  • Type 1-collagen

ASJC Scopus subject areas

  • Physiology
  • Hematology

Cite this

Effects of stable transfection of human fetal osteoblast cells with estrogen receptor-alpha on regulation of gene expression by tibolone. / Maran, A.; Shogren, K.; Zhang, M.; Yaszemski, Michael J; Hefferan, T. E.; Spelsberg, T. C.; Kloosterboer, H. J.; Turner, R. T.

In: Bone, Vol. 39, No. 3, 09.2006, p. 523-529.

Research output: Contribution to journalArticle

Maran, A, Shogren, K, Zhang, M, Yaszemski, MJ, Hefferan, TE, Spelsberg, TC, Kloosterboer, HJ & Turner, RT 2006, 'Effects of stable transfection of human fetal osteoblast cells with estrogen receptor-alpha on regulation of gene expression by tibolone', Bone, vol. 39, no. 3, pp. 523-529. https://doi.org/10.1016/j.bone.2006.03.006
Maran, A. ; Shogren, K. ; Zhang, M. ; Yaszemski, Michael J ; Hefferan, T. E. ; Spelsberg, T. C. ; Kloosterboer, H. J. ; Turner, R. T. / Effects of stable transfection of human fetal osteoblast cells with estrogen receptor-alpha on regulation of gene expression by tibolone. In: Bone. 2006 ; Vol. 39, No. 3. pp. 523-529.
@article{f41c72973b3140a5b4b2d9d87525ac11,
title = "Effects of stable transfection of human fetal osteoblast cells with estrogen receptor-alpha on regulation of gene expression by tibolone",
abstract = "Tibolone is a synthetic steroid which undergoes tissue selective metabolism into several metabolites having estrogenic, progestogenic or androgenic activities. The effects of 3α-hydroxy tibolone (Org 4094), 3β-hydroxy tibolone (Org 30126) and their sulfated metabolites were investigated on human fetal osteoblasts (hFOB). Tibolone had no effect on selected osteoblast marker proteins in estrogen-receptor negative hFOB cells. In contrast, 3α-hydroxy and 3β-hydroxy tibolone resulted in dose-dependent increases in alkaline phosphatase activity in estrogen receptor (ER) α-positive hFOB cells. The maximum increase for both metabolites was comparable to the effects of an optimal dose of 17β-estradiol, and occurred at 10 μM. At 20 μM, both metabolites increased mRNA levels for alkaline phosphatase and type 1 collagen and protein levels for osteocalcin. Sulfated metabolites of tibolone also increased alkaline phosphatase activity. The estrogen receptor antagonist ICI 182, 780 inhibited stimulation of alkaline phosphatase activity by sulfated and non-sulfated tibolone metabolites, but was more potent on the former. Taken together, these results suggest that stable transfection of ERα into hFOB cells confers regulation by 3α-hydroxy and 3β-hydroxy tibolone metabolites of osteoblast metabolism.",
keywords = "Alkaline phosphatase, Anti-estrogen, Bone formation, Osteoporosis, Type 1-collagen",
author = "A. Maran and K. Shogren and M. Zhang and Yaszemski, {Michael J} and Hefferan, {T. E.} and Spelsberg, {T. C.} and Kloosterboer, {H. J.} and Turner, {R. T.}",
year = "2006",
month = "9",
doi = "10.1016/j.bone.2006.03.006",
language = "English (US)",
volume = "39",
pages = "523--529",
journal = "Bone",
issn = "8756-3282",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Effects of stable transfection of human fetal osteoblast cells with estrogen receptor-alpha on regulation of gene expression by tibolone

AU - Maran, A.

AU - Shogren, K.

AU - Zhang, M.

AU - Yaszemski, Michael J

AU - Hefferan, T. E.

AU - Spelsberg, T. C.

AU - Kloosterboer, H. J.

AU - Turner, R. T.

PY - 2006/9

Y1 - 2006/9

N2 - Tibolone is a synthetic steroid which undergoes tissue selective metabolism into several metabolites having estrogenic, progestogenic or androgenic activities. The effects of 3α-hydroxy tibolone (Org 4094), 3β-hydroxy tibolone (Org 30126) and their sulfated metabolites were investigated on human fetal osteoblasts (hFOB). Tibolone had no effect on selected osteoblast marker proteins in estrogen-receptor negative hFOB cells. In contrast, 3α-hydroxy and 3β-hydroxy tibolone resulted in dose-dependent increases in alkaline phosphatase activity in estrogen receptor (ER) α-positive hFOB cells. The maximum increase for both metabolites was comparable to the effects of an optimal dose of 17β-estradiol, and occurred at 10 μM. At 20 μM, both metabolites increased mRNA levels for alkaline phosphatase and type 1 collagen and protein levels for osteocalcin. Sulfated metabolites of tibolone also increased alkaline phosphatase activity. The estrogen receptor antagonist ICI 182, 780 inhibited stimulation of alkaline phosphatase activity by sulfated and non-sulfated tibolone metabolites, but was more potent on the former. Taken together, these results suggest that stable transfection of ERα into hFOB cells confers regulation by 3α-hydroxy and 3β-hydroxy tibolone metabolites of osteoblast metabolism.

AB - Tibolone is a synthetic steroid which undergoes tissue selective metabolism into several metabolites having estrogenic, progestogenic or androgenic activities. The effects of 3α-hydroxy tibolone (Org 4094), 3β-hydroxy tibolone (Org 30126) and their sulfated metabolites were investigated on human fetal osteoblasts (hFOB). Tibolone had no effect on selected osteoblast marker proteins in estrogen-receptor negative hFOB cells. In contrast, 3α-hydroxy and 3β-hydroxy tibolone resulted in dose-dependent increases in alkaline phosphatase activity in estrogen receptor (ER) α-positive hFOB cells. The maximum increase for both metabolites was comparable to the effects of an optimal dose of 17β-estradiol, and occurred at 10 μM. At 20 μM, both metabolites increased mRNA levels for alkaline phosphatase and type 1 collagen and protein levels for osteocalcin. Sulfated metabolites of tibolone also increased alkaline phosphatase activity. The estrogen receptor antagonist ICI 182, 780 inhibited stimulation of alkaline phosphatase activity by sulfated and non-sulfated tibolone metabolites, but was more potent on the former. Taken together, these results suggest that stable transfection of ERα into hFOB cells confers regulation by 3α-hydroxy and 3β-hydroxy tibolone metabolites of osteoblast metabolism.

KW - Alkaline phosphatase

KW - Anti-estrogen

KW - Bone formation

KW - Osteoporosis

KW - Type 1-collagen

UR - http://www.scopus.com/inward/record.url?scp=33746750879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746750879&partnerID=8YFLogxK

U2 - 10.1016/j.bone.2006.03.006

DO - 10.1016/j.bone.2006.03.006

M3 - Article

C2 - 16707283

AN - SCOPUS:33746750879

VL - 39

SP - 523

EP - 529

JO - Bone

JF - Bone

SN - 8756-3282

IS - 3

ER -